Committee publication · Correspondence · 9 June 2026
Letter to Prologis relating to further information following the Committee's evidence session on 10 February on UK trade with the US, 23 April 2026
From: Business and Trade Committee
Inquiry: UK trade with the US
Summary
The Business and Trade Committee writes to Paul Weston of Prologis following his February oral evidence on UK-US trade barriers. The committee requests detailed information about governance complexity affecting Prologis's Cambridge Biomedical Campus investment plans, including specific infrastructure constraints, responsible bodies, investment timeline impacts, and whether Oxford-Cambridge scale governance would better address these obstacles.
Key findings
- Prologis has previously identified governance complexity ('quangocracy') as a barrier to UK investment at the Cambridge Biomedical Campus
- The Committee seeks clarity on major infrastructure constraints at the Cambridge site and which bodies are responsible
- Prologis suggests that Oxford-Cambridge scale governance may be more effective than Greater Cambridge alone for addressing investment obstacles
- The Committee questions whether similar constraints exist elsewhere in the UK and whether comparable solutions could be replicated
Tone
ProceduralTopics
business-investmentuk-us-tradeinfrastructureregional-governance
Key actors
Paul Weston, Prologis, Liam Byrne MP, Business and Trade Committee, Cambridge Biomedical Campus
Notable line
“The Committee would be grateful if you could provide a detailed account of the obstacles which have slowed progress in fulfilling Prologis's ambitions at the Cambridge site.”
Key Quotes
“I am writing to request further information on the governance complexity ("quangocracy") surrounding the Cambridge Biomedical Campus.”
Source · parliament.uk record ↗